miRNA-410 Control for Stem Cell Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective control over the differentiation of stem cells into specific cell types, such as astrocytes, neurons, and oligodendrocytes, and there is a need for targeted therapies for tumors involving these cell types.
Innovation Solution
Overexpressing or inhibiting miRNA-410 in stem cells using nucleic acid molecules, such as antagomirs or miRNA sponges, to direct differentiation into predominantly astrocytes, neurons, or oligodendrocytes, and using specific compounds to modulate miRNA-410 activity in tumors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If current differentiation methods are used, then stem cells can differentiate into various cell types, but the differentiation process lacks effective control over specific cell type production
Solution Approach 1:
The patent changes the biochemical parameter landscape by introducing specific miRNAs (miR-410, miR-9, miR-124) and their antagonists to control differentiation. By modulating miRNA expression levels and using complementary oligonucleotides, the invention achieves precise control over cell fate decisions without complicating the overall method framework
Solution Approach 2:
The patent uses miRNAs and complementary oligonucleotides as intermediary molecules to mediate between differentiation signals and target gene expression. These intermediaries provide a controllable mechanism to direct stem cells toward specific lineages (astrocytes, neurons, oligodendrocytes) by regulating gene silencing pathways
2Productivity
If miRNA-410 is overexpressed to produce astrocytes, then astrocyte differentiation is enhanced, but the ability to produce other cell types (neurons and oligodendrocytes) is reduced
Solution Approach 1:
The patent employs dynamic control of miRNA expression through inducible systems and temporal manipulation. By controlling when and how much miR-410 is expressed, the system can be tuned to produce different cell types at different time points, allowing high astrocyte productivity when needed while retaining the ability to produce other cell types in different experimental conditions
Solution Approach 2:
The patent uses partial inhibition of miR-410 with complementary oligonucleotides rather than complete blockade. This partial action allows fine-tuning of differentiation outcomes, where the degree of inhibition can be adjusted to achieve desired cell type ratios, balancing astrocyte production with retention of neuronal and oligodendrocyte generation capacity
3Adaptability or versatility
If antagomirs or miRNA sponges are used to inhibit miRNA-410, then neuronal and oligodendrocyte differentiation is promoted, but the complexity of the treatment increases
Solution Approach 1:
The patent extracts the specific inhibitory function from complex differentiation protocols by using isolated complementary oligonucleotides (antagomirs) that specifically target miR-410. This extraction allows the inhibition function to be added as a simple, discrete step to existing differentiation protocols, increasing cell type versatility without proportionally increasing overall treatment complexity
Solution Approach 2:
The patent uses synthetic complementary oligonucleotides that are simplified copies designed to specifically bind and inhibit miR-410. These copied sequences can be easily synthesized and applied, providing a simple yet effective means to promote neuronal and oligodendrocyte differentiation without requiring complex molecular biology tools
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Achieves efficient differentiation of stem cells into desired cell types and promotes tumor differentiation, offering potential therapeutic approaches for treating astroglial, neuronal, and oligodendrocyte-related tumors.
Implementation Method 1
miRNAs are small, single-stranded RNAs that play important roles in proliferation, differentiation, tumorigenesis, and apoptosis via their ability to silence target genes. miRNAs function primarily as repressors of gene expression, typically acting at the level of translational regulation of gene expression.
Implementation Method 2
the contacting further comprises using a lipid-based delivery system
Data Source
AI summary
Methods of producing populations of predominantly astrocytes, neurons or oligodendrocytes are provided. In addition, methods of treating mammals having astroglial tumors, oligodendrocyte tumors, or neuronal tumors are provided.